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Abstract
Background: T. cruzi strains have been divided into six discrete typing units (DTUs) according to their genetic background.
These groups are designated T. cruzi I to VI. In this context, amastigotes from G strain (T. cruzi I) are highly infective in vitro
and show no parasitemia in vivo. Here we aimed to understand why amastigotes from G strain are highly infective in vitro
and do not contribute for a patent in vivo infection.
Methodology/Principal Findings: Our in vitro studies demonstrated the first evidence that IFN-c would be associated to the
low virulence of G strain in vivo. After intraperitoneal amastigotes inoculation in wild-type and knockout mice for TNF-a,
Nod2, Myd88, iNOS, IL-12p40, IL-18, CD4, CD8 and IFN-c we found that the latter is crucial for controlling infection by G
strain amastigotes.
Conclusions/Significance: Our results showed that amastigotes from G strain are highly infective in vitro but did not
contribute for a patent infection in vivo due to its susceptibility to IFN-c production by host immune cells. These data are
useful to understand the mechanisms underlying the contrasting behavior of different T. cruzi groups for in vitro and in vivo
infection.
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Introduction
Chagas disease is a chronic, systemic, parasitic infection caused
by the protozoan Trypanosoma cruzi. The disease affects about 8
million people in Latin America, of whom 30–40% either have or
will develop cardiomyopathy, digestive megasyndromes, or both
[1]. Knowledge of the pathology and immune response to T. cruzi
infection has been largely obtained from murine models. These
models have shown that the innate and adaptive immune
responses play an important role in parasite control, depending
on the combined action of various cellular types including NK,
CD4+ and CD8+ as well as on the production of antibodies by B
cells [2–5]. Resistance to T. cruzi infection has been associated with
the production of the pro-inflammatory cytokines IL-12 and IFN-c
and with the local production of RANTES, MIP-1a, MIP-1b and
MCP-1. These cytokines activate the production of nitric oxide by
macrophages, which is responsible for elimination of the parasite
[6–9]. TNF-a has also been associated with macrophage activation
as a secondary signal for nitric oxide production [10]. In contrast,
cytokines such as IL-4 and TGF-b are associated with parasite
susceptibility [11,12].
T. cruzi strains have been divided into six discrete typing units
(DTUs) according to their genetic background. These groups are
designed T. cruzi I to VI [13]. The geographical distribution of
these groups indicate that T. cruzi II to VI are the main causal
agent of Chagas’ disease in the southern parts of South America,
with T. cruzi I only present in the sylvatic cycle [13–15]. In
contrast, in Colombia, Venezuela, and Central America T. cruzi I
have been reported as the primary parasite present in human cases
[16–18].
T. cruzi G strain (obtained from Nobuko Yoshida and originally
from Mena Barreto), isolated from an opossum in the Amazon
region, belongs to genotype I and shows a particular behavior;
Metacyclic trypomastigotes from G strain show low infectivity in
vitro and no in vivo parasitemia [19]. This phenotype was attributed
to the expression of a glycoprotein GP90, a stage specific negative
modulator of cell invasion [20]. Conversely amastigotes from G
strain are highly infective in vitro [21,22] but do not sustain a patent
infection in vivo (data not published), regardless that amastigotes
and blood stream trypomastigotes are the main forms encountered
during the disease progression. Indeed, the presence of blood
stream typomastigotes reflects the full completion of the
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developmental parasite life cycle program otherwise known to
proceed in the most frequent conditions. These results raised
questions that remained to be addressed along the past years. How
come amastigotes from G strain are highly infective in vitro and do
not contribute for a patent infection in vivo? How would the host
respond to the infection that complete abolishes parasitemia?
Thus, to gain insight concerning this issue we performed this study
that provided us a unique result; IFN-c production per se is
sufficient to control infection by G strain amastigotes. It is
extensively known the role of IFN-c in controlling intracellular
parasite infection [23–26]. However it is completely new for us
that this cytokine is unique in controlling infection by T. cruzi G
strain. It is generally observed that T. cruzi strains are sensible to
most of immune response mechanisms and also that are able to
overcome these responses establishing an acute phase character-
ized by parasitemia and animal death [6–9]. Indeed, this is the first
report which showed that the traditionally well known immune
response mechanism based on IFN-c production is sufficient to
control infection by low virulent T. cruzi G strain.
Methods
Animals
Female wild type BALB/c and C57BL/6 mice and also, iNOS,
Nod2, Myd88, IL-12p40, TNF-a, IFN-c, CD4, CD8, IL-18, gp91
phox subunit of NADPH oxidase knockout (KO) were provided
and maintained at the animal facilities of the Department of
Biochemistry and Immunology, School of Medicine of Ribeira˜o
Preto, USP (Ribeira˜o Preto, Brazil). Male or female mice were six
to eight weeks old and were kept under standard conditions on a
12-h light, 12-h dark cycle in a temperature-controlled room
(2562uC) with food and water ad libitum Maintenance and care of
these animals complied with the guidelines of the Laboratory
Animal Ethics Committee from the Institution. Animal euthanasia
was performed in accordance with international welfare grounds,
according to the American Veterinary Medical Association
Guidelines on Euthanasia.
Parasites and cells
T. cruzi from G was maintained in Vero cells culture. To obtain
the amastigotes forms, trypomastigotes were incubated in LIT
medium (liver infusion tryptose), pH 5.8 overnight. Vero, HeLa
and MEF (murine embryonic cells) cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco BRL,
Gaithersburg, MD) with L-glutamine and Dglucose (4500 mg/L),
sodium bicarbonate (2000 mg/L), HEPES (2380 mg/L), sodium
pyruvate (1100 mg/L), supplemented with Fetal bovine serum
(10%) and Penicillin (60 mg/L), gentamicin (40 mg/L) and
streptomycin (10 mg/L). Cells were grown at 37uC with 5%
CO2 in cell plates.
In vitro multiplication assay
HeLa and MEF cells were plated into 24 wells plate (105 cells/
well). Each well contained a 13 mm round coverslips and were left
overnight. After, amastigotes from G (20 parasites/cell) strain were
put in contact with cells for 3 hours.After, wells were washed three
times with PBS to remove non-internalized parasites. 3 and
48 hours post-infection cells were fixed with Bouin solution and
Giemsa stained. Then, coverslips were glued onto glass slides.
Number of internalized parasites and multiplication were counted
in a total of 100 infected cells. The experiment was performed in
triplicate and three times.
Ex-vivo multiplication assay in inflammatory peritoneal
macrophages
Inflammatory peritoneal macrophages, from C57BL/6, were
recruited with the injection of thioglicollate 3% (3 g/L). Two days
after, animals were intraperitoneally injected with 105 amastigotes
from G strain and macrophages extracted only after 3 hours. The
cells were plated into 24 well plates (56105 cells/well). Finally,
cells were Bouin fixed and Giemsa stained, 48 and 72 hours post-
inoculation and number of internalized parasites was counted in a
total of 100 infected macrophages. The experiment was performed
in triplicate and three times.
Release assay
Undifferentiated cells were extracted from C57BL/6 bone
marrow. Primarily, the femur of mice was withdrawn and cells
were extracted with a PBS squirt into the marrow. Afterwards,
these cells were placed on a Petri dish with a medium containing
20% of fetal bovine serum and 30% of the supernatant of L929
cell line which secretes M-CSF (macrophage colony-stimulating
factor) a macrophage differentiated factor. Once differentiated,
cells were plated in a 96 well plate, some of them stimulated with
10 or 100 ng/mL of IFN-c and others not. Subsequently, cells
were infected with amastigotes from G strain (20 parasites/cell)
and the release of trypomastigotes was observed over ten days.
Parasitemia and mortality analysis
BALB/c, C57BL/6 and iNOS, TNF-a, IL-12p40, IL-18, CD4,
CD8, IFN-c and gp91 phox subunit of NADPH oxidase KO
animals were intraperitoneally inoculated with 105 amastigotes
from G strain. Each group was composed of five animals. Blood
was collected from animal orbital plexus and 5 mL was placed on a
slide to parasitemia analyses. Parasitemia and animals mortality
was observed over thirty days post-inoculation.
Parasitemia and mortality analysis of inoculated and
immunosuppressed mice
C57BL/6 mice were intraperitoneally inoculated with 105
amastigotes from G strain. Each group was composed of five
animals. Ten days after inoculation, the animals were immuno-
suppressed with Decadron (dexamethasone) 10 mg/mL. The
medication was added to the water bottle of the immunossup-
Author Summary
Trypanosoma cruzi, an obligate intracellular protozoan, is
the etiological agent of Chagas disease that represents an
important public health burden in Latin America. The
infection with this parasite can lead to severe complica-
tions in cardiac and gastrointestinal tissue depending on
the strain of parasite and host genetics. Currently, six
genetic groups (T. cruzi I to VI) have been identified in this
highly genetic and diverse parasite.The majority of
published data concerning host immune response has
been obtained from studying T. cruzi II to VI-infected mice,
and the genetic differences between T. cruzi II to VI and T.
cruzi I strains are large. Here we aimed to understand how
amastigotes from T. cruzi I G strain are highly infective in
vitro and do not contribute for a patent parasitemia in vivo.
Our results showed that amastigotes from G strain are
highly susceptible to IFN-c treatment in vitro and secretion
by immune cells in vivo. This information may represent
important findings to design novel immune strategies to
control pathology that may be caused by different strains
in the same host.
IFN-c Controls Low Virulent T. cruzi Strain
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pressed groups. Control groups were given just water. Blood was
collected from animal tail and 5 mL was placed on a slide to
parasitemia analyses. Parasitemia and animals mortality was
observed over forty days post-inoculation.
Flow cytometry
C57BL/6 mice were intraperitoneally inoculated with 105
amastigotes from G strain. Each group was composed of four
female animals. Control group was not infected. Blood was
collected through orbital plexus at 8 and 25 days post-inoculation.
Lymphocytes were separated from other blood cells using Ficoll-
PaqueTM gradient (Amersham Biosciences).Cells were washed
with FACS buffer, counted, and 56105cells were labeled with
CD16/32-APC and CD69-PE or NK1.1-PE (BD). NK1.1 is a
surface molecule expressed in NK cells in selected strains of mice,
including C57BL/6 (an specific marker); CD16 and/or CD32 are
expressed on NK, monocytes, macrophages, dendritic cells,
kupffer cells, granulocytes, mast cells, B lymphocytes, immature
thymocytes and some activated mature T lymphocytes (here an
unspecific marker); CD69 is expressed upon activation of
lymphocytes (T, B, NK, and NK-T cells), neutrophils and
macrophages, also on IL-2 activated NK cells (an activation
marker).The samples were acquired by FACSCantoII (BD), and
the results were analyzed by FlowJo software (version 7.6.3).
Statistical analyses
The significance of experiments was determined by one way
ANOVA performed according to VassarStats program (Richard
Lowry 1998–2006), available http://faculty.vassar.edu/lowry/
VassarStats.html or by GraphPad Prism program, version 5.01
for Student-t analysis. The results were considered significant
when p,0.05.The mortality analysis was performed by a survival
curve according to GraphPad Prism program.
Results
Amastigotes from G strain provided a patent in vitro
infection. On the other hand, was rapidly controlled in
vivo but was not completely eliminated
Invasion assays using amastigotes from G strain were performed
during 3 hours and the multiplication verified 48 h post HeLa and
MEF cells invasion. The results showed that G strain amastigotes
showed high invasion and multiplication indexes in both
mammalian cell lines (Figure 1 A and B). Also, 80 to 90% of
cells were infected by the parasite. However, when BALB/c and
C57BL/6 mice were intraperitoneally inoculated with amastigotes
from G strain, no parasitemia was observed in both animal models
(Figure 1 C). One could argue that this T. cruzi strain would be
non-virulent. Nonetheless, in immunossupressed C57BL/6 ani-
mals, parasitemia reached high peak after 24 days post-inoculation
(Figure 1 D).
IFN-c controls G strain amastigotes infection
In order to verify the impact of different host immune
components in protection against infection by amastigotes from
T. cruzi G strain we performed a screening using different
knockout mice model. First, we inoculated Myd88, Nod2, CD4
and CD8 KO animals. The results showed no change in the
course of infection and mortality comparing to WT mice (Figure 2
a, b, c, d, e, f, g, and h). After, we verified if cytokines would play
any role in animal protection against amastigotes from T. cruzi G
strain infection. In this sense, we used TNF-a, IL-18, IL-12 and
IFN-c KO mice. We observed that deficiency on TNF-a and IL-
18 secretion did not have impact on parasitemia and animal
survival (Figure 3 b, c, f and g). On the other hand, IL12p40 KO
mice showed parasitemia on the 12 day post-inoculation (p,0.01)
and 40% of mortality by the 30 post-inoculation (p,0.01) (Figure 3
a and e). Moreover, IFN-c KO mice presented a high parasitemia
peak by the 16 day post-inoculation (p,0.001) and all animals
died by the 24 day (p,0.01) (Figure 3 d and h). These results
turned our attention to the role of macrophages during T. cruzi G
strain clearance. To gain insight about this issue, we performed an
ex vivo assay. For that purpose, C57BL/6 mice were intraperito-
neally inoculated with amastigotes from G strain for 3 h.
Inflammatory peritoneal macrophages were collected and seeded
into coverslips. After 48 and 72 h of culture the number of
intracellular amastigotes was counted. It was observed that G
strain amastigotes did not multiply intracellularly in the macro-
phage cultures (Figure 4 A). Moreover, naive macrophages
obtained from C57BL/6 mice bone marrow undifferentiated cells
were in vitro infected with amastigotes from G strain and the
number of trypomastigotes in the supernatant was counted after
three, five and seven days of infection and treatment or not with
different concentrations of IFN-c. The number of trypomastigotes
from G strain in the supernatant was higher in non-treated cells
(p,0.001), showing that naive macrophages could not impair
parasite multiplication and differentiation. However, the number
of released parasites was dramatically reduced in treated cells in an
IFN-c dose dependent manner (Figure 4 B). The next step was to
identify the mechanism activated by macrophages during parasite
clearance. For that purpose we inoculated amastigotes from G
strain in iNOS and gp91 KO mice. However, the results showed
no difference in the course of infection, neither on the mortality
rates (Figure 5 a, b, c and d).
NK cells are recruited early during infection by G strain
amastigotes
One important question raised by our results is the source of
IFN-c, since CD4 and CD8 cells seemed not to play an important
role. Also, it is worth mentioning that the control occurred during
the first days after inoculation. Thus, we performed flow cytometry
in order to verify if NK cells were recruited during infection. The
results showed that in non inoculated animals the lymphocytes
population in peripheral blood were stained neither for CD16/32
nor for NK1.1 and CD69, indicating a phenotype of inactivated T
cells (Figure 6 b and c). However, when we observed the animals
by 8 days post-inoculation, we were capable of identifying another
distinct cell population, which was denominated of ‘‘large granular
lymphocytes’’ (LGL). It is know that the NK cells are largest than
other lymphocytes and they have granular contents. Thereby, this
LGL population had the same NK cells phenotype. We observed
that this population was mostly double positive to CD16/32 and
NK1.1 (Figure 6 d9) or CD69 (Figure 6 e9), confirming NK
phenotype, and that they were activated. Afterward, our results
demonstrated a dramatic increase in activated NK cell by the 8
day post-inoculation (p,0.001) (Figure 6 a9, d9, and e9), however
this behavior was not maintained in 25 day post-inoculation,
returning to basal levels (Figure 6 a0 d0 and e0).
Discussion
T. cruzi is a very heterogeneous flagellate parasite; and its
populations are characterized by a diverse morphology, a
heterogeneous biological behavior, a high genetic variability, and
distinctly different clinical courses. The clonal-histotropic model of
Chagas’ disease [27] describes a correlation between the clonal-
population structure of T. cruzi and its tissue tropism; and it gives a
IFN-c Controls Low Virulent T. cruzi Strain
www.plosntds.org 3 April 2012 | Volume 6 | Issue 4 | e1598
possible explanation for the variety shown by this parasite. It is
now accepted that T. cruzi strains can be divided into six DTUs, T.
cruzi I to VI [13].
To our awareness this is the first study that evaluated the
immune response against T. cruzi amastigotes from strain
belonging to group I. In this context, understanding the way host
responds to amastigotes is quite important, once amastigotes are
the main forms encountered during the chronic phase of the
disease. Our first observation is that infection by amastigotes from
G strain did not activate signal pathway dependent on Myd88 nor
reliant on Nod2 receptor. Probably other innate immune response
related receptors are triggered during amastigotes infection. This
issue will be addressed in additional studies. Infection in other
knockout animals showed that G strain amastigotes were only
susceptible to IL-12 and IFN-c production. The major cytokine
responsible for IFN-c secretion is IL-12. However we observed just
a low peak of parasitemia in IL-12 KO mice. This result may be
explained by the fact that IL-18 also induces IFN-c secretion.
Moreover, IL-18 KO mice showed no parasitemia. Thus, these
results showed the redundant role of these cytokines in inducing
IFN-c production and infection control. A double knockout mice
model for both cytokines would be helpful to sustain this
hypothesis.
IFN-c is an important mediator of resistance to T. cruzi. Besides
iNOS, IFN-c regulates the expression of a large number of genes,
including chemokines and chemokine receptors, which were
shown to play a role in IFN-c mediated protection in T. cruzi
infection. Early during infection, IFN-c is secreted by NK cells and
other cell types, as part of the innate response, and later on the
infection course by activated CD4+ and CD8+ T cells [23–25].
Recently, authors demonstrated for the first time in vivo, the
specific importance of direct IFN-c mediated activation of
macrophages for controlling infection with multiple protozoan
parasites [26]. Here we observed that IFN-c plays crucial and
unique role in controlling infection by amastigotes from T. cruzi G
strain.
Nitric oxide (NO) and reactive oxygen species (ROS) are two
key inflammatory mediators involved not only in pathogen
clearance but also in tissue injury. Nitric oxide is produced by
different isoforms of NO synthase, among them the inducible
isoform (iNOS) that is activated by IFN-c and TNF-a [28]. During
T. cruzi infection, NO can directly or indirectly modulate the
effector leukocyte machinery through diverse mechanisms. This
process involves microbicidal effects derived from toxic-free
radicals (peroxinitrite and superoxide) generated after NO
production, as well as regulation/enhancement of the inflamma-
tory response induced during this type of infection, a dual role in
the immunity that is usually observed for NO. This well-known
immune duality is usually dependent on concentration and, once
dysregulated, may lead to host cell toxicity, autoimmunity or
parasite persistence due to immune evasion, all of which can lead
to pathology. NO is involved in the control of T. cruzi-induced
parasitemia and directly kills the parasite in vitro. NO affects T.
cruzi by chemically modifying cysteine-containing proteins and/or
Figure 1. G strain parasitemia is only detected after dexmethasone treatment. G strain amastigote progeny is generated in Hela and MEF
cells in vitro but no trypomastigotes are released at a detectable level in the bloodstream in C57BL/6 mice except if the latter are given
dexmethasone. Amastigotes from G strain invasion (A) and multiplication (B) in HeLa and MEF cells. Parasitemia was not observed in wild type
C57BL/6 and BALB/c mice (C). C57BL/6 mice that were given 100,000 amastigotes intraperitoneally at day 0 and that were given dexamethasone from
day 10 onward displayed parasitemia from days 24 post amastigote inoculation (D). *p,0.001.
doi:10.1371/journal.pntd.0001598.g001
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by binding to metallo-proteins that mediate crucial metabolic
processes. The strength of NO toxicity is dependent on the
sensitivity of the parasite, which differs among parasite strains and
according to the physiological microenvironment [29]. Moreover,
Oxidative burst of activated phagocytes results in the release of
ROS, e.g., superoxide (O2
N2), hydrogen peroxide (H2O2), and
Figure 2. Whatever gene (CD4, CD8, Nod2 and Myd88) deletion, trypomastigotes were never detected in mice bloodstream. Wild
type and CD4 (a, e), CD8 (b, f) Nod2 (c, g) and Myd88 (d, h) knockout mice mice were given intraperitoneally 100,000 G strain amastigotes. Parasitemia
values were monitored in mouse blood at 7, 12, 19 and 26 days post-inoculation; survival was checked every day until 30 post-inoculation . (n = 5
mice per group).
doi:10.1371/journal.pntd.0001598.g002
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hydroxyl radical, via activation of NADPH oxidase (NOX) and/or
myeloperoxidase (MPO) enzymes. The inflammatory cytokines
and ROS are important for the control of T. cruzi and may be
cytotoxic to the host cellular components. Many of the ROS are
highly reactive and diffusible and may be released into the
extracellular milieu. Whereas intracellular ROS serve mainly for
host defense against infectious agents, the extracellular release of
ROS, when present in abundance, directly damages the
surrounding tissues or promotes inflammatory processes (revised
in [30]). Our results obtained from iNOS and gp91 KO mice
Figure 3. Deletion in IL12p40 and IFN-c induced bloodstream parasitemia. Though with distinct profiles, in mice genetically deleted from
either IL12p40, IFN-c, the G strain trypomastigote progeny was detected in the bloodstream, while in mice deleted from either IL-18 or TNF-a, no
trypomastigote progeny was detected. Wild type and IL-12p40 (a, e), IL-18 (b, f), TNF-a (c, g) and IFN-c (d, h) knockout mice were given
intraperitoneally 100,000 G strain amastigotes. Parasitemia values were monitored in mouse blood at 7, 12, 19 and 26 days post-inoculation; survival
was checked every day until 30 post-inoculation . (n = 5 mice per group). It was observed parasitemia peak and mortality only for IL-12p40 and IFN-c
KO mice. *p,0.01; ***p,0.001.
doi:10.1371/journal.pntd.0001598.g003
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showed no parasitemia during the 30 days post-inoculation.
Thus, is conceivable to believe that NO and ROS may play
redundant role during parasite clearance. Another hypothesis
that does not completely exclude the first is that other
mechanisms of parasite clearance would be activated by G strain
parasites, such as a group of IFN-c induced genes that plays a
major role in host control of intracellular pathogens. These genes
belong to a family encoding a series of 47- to 48-kDa GTPases for
instance LRG-47 that can influence T. cruzi Y strain control by
simultaneously regulating macrophage-microbicidal activity and
hemopoietic function [31].
Our results showed the impact of innate immune response in
controlling infection by amastigotes from G strain. In addition,
CD4 and CD8 KO mice showed no difference in the infection
course. This information may represent important finding to
design novel immune strategies focused on enhancing the innate
immune response to control pathology that may be caused by
different strains of the parasite in the same host.
Figure 4. Inflamatory and IFN-c treated naive macrophages impaired cell-cycling trypomastigotes differentiate from amastigotes.
Amastigotes did not multiply in inflammatory peritoneal macrophages in an ex-vivo assay (A). Treatment with recombinant IFN-c controlled in a dose
dependent manner trypomastigotes release from bone marrow derived naive macrophages (B) (p,0.001).
doi:10.1371/journal.pntd.0001598.g004
Figure 5. In iNOS and gp91 KO mice no trypomastigote progeny was detected. Wild type, iNOS (a, c) and gp91 KO (b, d) mice were given
intraperitoneally 100 000 G strain amastigotes. Parasitemia values were monitored in mouse blood at 7, 12, 19 and 26 days post-inoculation ; survival
was checked every day until 30 post-inoculation . (n = 5 mice per group).
doi:10.1371/journal.pntd.0001598.g005
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Figure 6. Monitoring presence of activated NK cells in bloodstream post amastigote intraperitoneal inoculation. Flow cytometry was
performed with mononuclear cells prepared from mice left without any inoculation (a, b, c, d and e), and mice that were given intraperitoneal G strain
amastiogotes at day-8 post-inoculation (a9, b9, c9, d9 and e9) at day-25 (b0, c0, d0 and e0). Note the higher percentage of activated NK cells at day-8
post-inoculation (p,0.01). Gates: L – lymphocytes and LGL – large granular lymphocytes (NK cells).
doi:10.1371/journal.pntd.0001598.g006
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To gain insight into the source of IFN-c production, we
performed flow cytometry and observed that the lymphocyte
population in the peripheral blood samples showed an inactivated
phenotype in infected and non infected animals. While in infected
animals, we observed a significant increase in NK population with
an activated phenotype. This result suggested that the main source
of IFN-c produced to protect animal against amastigotes from T.
cruzi G strain is NK cells. However, depletion of NK cell in WT
and IFN-c KO mice would be interesting to confirm the
hypothesis.
In conclusion, our research showed that although amastigotes
from G strain were highly infective in vitro they did not induce a
patent infection in vivo due to the high susceptibility to IFN-c
production early in infection. This study highlighted the need to
consider strain biases when investigating host immune response
against T. cruzi.
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